logo-loader

Concepta appoints former CEO of Genedrive as new chairman

Published: 16:23 17 Jul 2018 AEST

Board room
Walls was previously global commercial director at FTSE 100 pharma giant AstraZeneca

Concepta PLC (LON:CPT) has appointed the former chief executive of Genedrive PLC (LON:GDR) as its new chairman while also appointing a new non-executive director.

The AIM-listed fertility aid manufacturer said Matthew Walls would become chairman of the company with immediate effect, while former chairman Adam Reynolds would move to the role of non-executive director.

WATCH: Concepta PLC making progress after steep learning curve in China

Walls previously held roles as chief executive and chairman of patient behavioural change company Atlantis Healthcare Group, chairman and advisory roles for The Fertility Partnership, the UK’s largest fertility group, as well as chief executive of AIM-listed molecular diagnostics company Genedrive.

Walls also held the role of global commercial director at FTSE 100 pharma giant AstraZeneca PLC (LON:AZN), with commercial and financial responsibility for strategy and international business operations.

Erik Henau, Concepta chief executive, said: "[Walls’] fantastic track record in achieving commercial success and knowledge of corporate governance, regulatory issues, and delivery of strategic plans in the healthcare arena will be instrumental to Concepta as it enters this important phase in its expansion.”

The firm also said it had appointed Peter Dines, the current chief operating officer & head of life sciences and biosciences at Marcia Technologies, Concepta’s major shareholder, as a non-executive director with immediate effect while Dr Mark Wyatt would step down from his own non-executive director role to focus on other business interests.

Henau said: “With over 20 years' experience in managing growth businesses in the healthcare and pharma sector, Peter will be a welcome addition to the Board and will further strengthen our team as we continue to scale the business.”

Australian Strategic Materials signs US$600 million LoI

Rowena Smith, CEO and managing director of Australian Strategic Materials Ltd (ASX:ASM, OTC:ASMMF), joins Jonathan Jackson in the Proactive studio to discuss the company’ s Dubbo Project, in Central West New South Wales. This project aims to extract and process critical minerals and rare earth...

3 hours, 22 minutes ago